Unknown

Dataset Information

0

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor.


ABSTRACT: Hypoxia inducible factors (HIFs) are transcription factors that activate expression of multiple gene products and promote tumor adaptation to a hypoxic environment. To become transcriptionally active, HIFs associate with cofactors p300 or CBP. Previously, we found that arylsulfonamides can antagonize HIF transcription in a bioassay, block the p300/HIF-1? interaction, and exert potent anticancer activity in several animal models. In the present work, KCN1-bead affinity pull down, (14)C-labeled KCN1 binding, and KCN1-surface plasmon resonance measurements provide initial support for a mechanism in which KCN1 can bind to the CH1 domain of p300 and likely prevent the p300/HIF-1? assembly. Using a previously reported NMR structure of the p300/HIF-1? complex, we have identified potential binding sites in the p300-CH1 domain. A two-site binding model coupled with IC50 values has allowed establishment of a modest ROC-based enrichment and creation of a guide for future analogue synthesis.

SUBMITTER: Shi Q 

PROVIDER: S-EPMC4056939 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor.

Shi Qi Q   Yin Shaoman S   Kaluz Stefan S   Ni Nanting N   Devi Narra Sarojini NS   Mun Jiyoung J   Wang Danzhu D   Damera Krishna K   Chen Weixuan W   Burroughs Sarah S   Mooring Suazette Reid SR   Goodman Mark M MM   Van Meir Erwin G EG   Wang Binghe B   Snyder James P JP  

ACS medicinal chemistry letters 20120621 8


Hypoxia inducible factors (HIFs) are transcription factors that activate expression of multiple gene products and promote tumor adaptation to a hypoxic environment. To become transcriptionally active, HIFs associate with cofactors p300 or CBP. Previously, we found that arylsulfonamides can antagonize HIF transcription in a bioassay, block the p300/HIF-1α interaction, and exert potent anticancer activity in several animal models. In the present work, KCN1-bead affinity pull down, (14)C-labeled KC  ...[more]

Similar Datasets

| S-EPMC5320473 | biostudies-other
| S-EPMC2034469 | biostudies-literature
| S-EPMC114560 | biostudies-literature
| S-EPMC3760798 | biostudies-literature
| S-EPMC9274749 | biostudies-literature
| S-EPMC2780727 | biostudies-literature
| S-EPMC5641081 | biostudies-literature
| S-EPMC5682953 | biostudies-literature
| S-EPMC5389469 | biostudies-literature
| S-EPMC4057186 | biostudies-literature